scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1050775178 |
P356 | DOI | 10.1007/S13277-015-4317-Y |
P698 | PubMed publication ID | 26526580 |
P50 | author | Rui Manuel Reis | Q49550849 |
Fatima Baltazar | Q51599151 | ||
F M Cárcano | Q84289404 | ||
Paula Soares | Q37840702 | ||
Daniel Onofre Vidal | Q43507414 | ||
Herlander Marques | Q47101515 | ||
P2093 | author name string | Cristovam Scapulatempo Neto | |
Luiz Fernando Lopes | |||
André van Helvoort Lengert | |||
Camila Maria da Silva Martinelli | |||
Eduardo Caetano Albino da Silva | |||
Luisa Queiroz | |||
P2860 | cites work | Stem cell factor activates telomerase in mouse mitotic spermatogonia and in primordial germ cells. | Q48863717 |
Microsatellite instability, mismatch repair deficiency, and BRAF mutation in treatment-resistant germ cell tumors. | Q51766708 | ||
Telomerase activity in germ cell cancers and mature teratomas. | Q52175357 | ||
TERT promoter mutations in soft tissue sarcomas. | Q53337795 | ||
TERT promoter mutations in clear cell renal cell carcinoma. | Q54314475 | ||
Mutations of BRAF and RAS are rare events in germ cell tumours. | Q54700314 | ||
International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group | Q56474871 | ||
Germ cell-like telomeric length homeostasis in nonseminomatous testicular germ cell tumors | Q74234890 | ||
An integrated map of genetic variation from 1,092 human genomes | Q22122153 | ||
Hallmarks of Cancer: The Next Generation | Q22252312 | ||
Variants near DMRT1, TERT and ATF7IP are associated with testicular germ cell cancer | Q29417028 | ||
Highly recurrent TERT promoter mutations in human melanoma | Q29614798 | ||
TERT promoter mutations in familial and sporadic melanoma | Q29614920 | ||
Expression level of hTERT is regulated by somatic mutation and common single nucleotide polymorphism at promoter region in glioblastoma | Q33917659 | ||
Alternative lengthening of telomeres: models, mechanisms and implications | Q34107386 | ||
TERT promoter mutations are a major indicator of poor outcome in differentiated thyroid carcinomas | Q34313648 | ||
Treatment of testicular cancer: a new and improved model | Q34568793 | ||
A phase II trial of TIP (paclitaxel, ifosfamide and cisplatin) given as second-line (post-BEP) salvage chemotherapy for patients with metastatic germ cell cancer: a medical research council trial | Q36615043 | ||
Interpreting the international trends in testicular seminoma and nonseminoma incidence. | Q36619297 | ||
Low frequency of TERT promoter mutations in gastrointestinal stromal tumors (GISTs). | Q36695151 | ||
TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal | Q36762656 | ||
High frequency of telomerase reverse-transcriptase promoter somatic mutations in hepatocellular carcinoma and preneoplastic lesions | Q37064910 | ||
TERT promoter mutations in bladder cancer affect patient survival and disease recurrence through modification by a common polymorphism | Q37256055 | ||
Expression, mutation and copy number analysis of platelet-derived growth factor receptor A (PDGFRA) and its ligand PDGFA in gliomas. | Q37345320 | ||
TERT promoter mutations in cancer development | Q38198430 | ||
Telomerase promoter mutations in cancer: an emerging molecular biomarker? | Q38232447 | ||
Cancer. The transcription factor GABP selectively binds and activates the mutant TERT promoter in cancer. | Q38874534 | ||
Frequency of TERT promoter mutations in human cancers | Q39120274 | ||
Short tandem repeat DNA typing provides an international reference standard for authentication of human cell lines. | Q40410208 | ||
TERT promoter mutations in skin cancer: the effects of sun exposure and X-irradiation. | Q42456732 | ||
Prognostic Factors in Patients With Metastatic Germ Cell Tumors Who Experienced Treatment Failure With Cisplatin-Based First-Line Chemotherapy | Q42855201 | ||
Quantification of human telomerase reverse transcriptase mRNA in testicular germ cell tumors by quantitative fluorescence real-time RT-PCR. | Q44094702 | ||
Cisplatin and etoposide in childhood germ cell tumor: brazilian pediatric oncology society protocol GCT-91. | Q46151039 | ||
P433 | issue | 4 | |
P304 | page(s) | 4901-4907 | |
P577 | publication date | 2015-11-03 | |
P1433 | published in | Tumor Biology | Q15757842 |
P1476 | title | Hotspot TERT promoter mutations are rare events in testicular germ cell tumors | |
P478 | volume | 37 |
Q47379639 | HoxC5 and miR-615-3p target newly evolved genomic regions to repress hTERT and inhibit tumorigenesis |
Q52620813 | Implications of TERT promoter mutations and telomerase activity in urothelial carcinogenesis. |
Q26739948 | Telomerase: The Devil Inside |
Q26739925 | Transcription Regulation of the Human Telomerase Reverse Transcriptase (hTERT) Gene |
Q38760235 | Understanding TERT Promoter Mutations: A Common Path to Immortality. |
Search more.